Dermatology Podcast ArchivesFeatured PodcastPodcast Highlights

Aspiring Higher: Research Tales from Pfizer Grant Awardees – Jonathan Zippin, MD

By September 12, 2022No Comments

JDD Multimedia

JDD Podcast

Aspiring Higher: Research Tales from Pfizer Grant Awardees – Jonathan Zippin, MD

Jonathan Zippin, MD, PhD & Adam Friedman, MD, FAAD

No one wants to be a one grant wonder. The mantra “grants beget grants” is true but there is more method to the madness to ensure continued success. Tune in to hear how Dr. Jonathan Zippin, Vice Chair of Research, Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell approaches grant wins and losses, and ensures continued green to support the research machine.

This educational podcast is supported by Pfizer Inc.

Listen Now
HOST: Adam Friedman, MD, FAAD
GUEST: Jonathan Zippin, MD, PhD

You May Also Like

The Nuts and Bolts (or Berries) of Nutraceutical Regulation and Development: A Natural Review

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Spotify Isabelle Raymond, PhD Supplements, serums, infused soaps oh my! The over the counter space is a vast dermatology multiverse which can easily knock you…

Behind the Bottle: Poring Through the Flavors of Evidence to Optimize Over the Counter (OTC) Product Recommendations

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Spotify Dr. Peter Lio “What should I buy, what should I use, do I need skin care?” Sound familiar? Whether it be a patient or…

Wondering about Words: Evidence Based Framing for Improving Treatment Adherence

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Spotify Hosts: Dr. Adam Friedman and Dr. Steven Feldman Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This…

Leave a Reply